Cardlytics, Inc. (CDLX) financial statements and ratios from SEC XBRL: revenue $233.27M (TTM), net margin -44.4%, revenue growth -41.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $233.27M |
| Net Margin | -44.4% |
| Revenue Growth (YoY) | -41.7% |
| FCF Growth (YoY) | -1052.3% |
| Price / Sales | 0.14 |
| FCF Yield | 1.8% |
| Altman Z-Score | -6.51 (distress) |
| Sector P/E (Technology) | 33.9 |
CDLX overview · CDLX earnings · CDLX KPIs · CDLX investor relations · CDLX ownership · CDLX peers · CDLX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.